Your browser doesn't support javascript.
loading
Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αß+ T cells targeting multiple myeloma.
Bae, Jooeun; Kitayama, Shuichi; Herbert, Zach; Daheron, Laurence; Kurata, Keiji; Keskin, Derin B; Livak, Kenneth; Li, Shuqiang; Tarannum, Mubin; Romee, Rizwan; Samur, Mehmet; Munshi, Nikhil C; Kaneko, Shin; Ritz, Jerome; Anderson, Kenneth C.
Afiliación
  • Bae J; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Kitayama S; Harvard Medical School, Boston, MA.
  • Herbert Z; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Daheron L; Harvard Medical School, Boston, MA.
  • Kurata K; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Keskin DB; Harvard Medical School, Boston, MA.
  • Livak K; Harvard Stem Cell Institute, Harvard University, Cambridge, MA.
  • Li S; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Tarannum M; Harvard Medical School, Boston, MA.
  • Romee R; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Samur M; Harvard Medical School, Boston, MA.
  • Munshi NC; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Kaneko S; Harvard Medical School, Boston, MA.
  • Ritz J; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Anderson KC; Harvard Medical School, Boston, MA.
Blood ; 143(10): 895-911, 2024 Mar 07.
Article en En | MEDLINE | ID: mdl-37890146

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígenos CD8 / Células Madre Pluripotentes Inducidas / Mieloma Múltiple / Antineoplásicos Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígenos CD8 / Células Madre Pluripotentes Inducidas / Mieloma Múltiple / Antineoplásicos Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article